Coenzyme Q10 (CoQ10) is a naturally occurring, lipid-soluble compound synthesized by the body that has been extensively studied for its role in supporting cardiovascular health,  mitochondrial energy production, and healthy aging. Despite the large body of research on CoQ10, an important question continues to arise among practitioners and patients: does the form of CoQ10 (ubiquinone or ubiquinol) matter? While discussions often focus on differences between these two forms, emerging evidence suggests that delivery system and formulation quality may play an equally important, and sometimes even greater, role in determining CoQ10 bioavailability.

Understanding the Two Forms of CoQ10

CoQ10 naturally exists in two biologically active, interconvertible forms: ubiquinone (oxidized) and ubiquinol (reduced). Within the mitochondrial electron transport system, CoQ10 undergoes continuous and reversible redox cycling, being converted to ubiquinol when it accepts electrons and oxidized back to ubiquinone when it donates electrons. This reversible redox cycling enables CoQ10 to participate in multiple cellular processes and biochemical pathways.

Within the mitochondria, ubiquinone functions as an electron carrier in the electron transport chain, supporting the generation of adenosine triphosphate (ATP), the primary energy source used by cells. During this process, ubiquinone accepts electrons and is converted to ubiquinol. When ubiquinol subsequently donates electrons during metabolic reactions or antioxidant processes, it is oxidized back to ubiquinone. In its reduced form, ubiquinol contributes to antioxidant activity by donating electrons that help limit oxidative processes affecting cellular membranes and circulating lipoproteins. This continuous redox cycling between ubiquinone and ubiquinol is central to CoQ10’s biological activity.

The body maintains a dynamic balance between ubiquinone and ubiquinol, as the two forms readily interconvert during metabolic and redox reactions. On average, circulating CoQ10 in humans exists predominantly in the reduced (ubiquinol) form, with approximately 95% of plasma CoQ10 present as ubiquinol, highlighting the body’s ability to readily convert between the two forms as part of normal cellular metabolism.

Because ubiquinol is already in the reduced form, it is sometimes suggested that it may be more readily absorbed than ubiquinone. Some randomized crossover studies have reported higher plasma CoQ10 concentrations following ubiquinol supplementation than with equivalent doses of ubiquinone, particularly in men aged 55 and older (n = 10) and in healthy volunteers aged 29 to 50 (n = 12). However, another randomized crossover study (n = 21) with healthy adults ages 65 to 74 reported no statistically significant differences in bioavailability between the two forms. The researchers found that approximately 90% of circulating CoQ10 appeared in the reduced ubiquinol form, regardless of whether ubiquinone or ubiquinol was consumed, highlighting conversion during digestion and absorption. 

Experimental evidence further suggests that ubiquinol may be chemically unstable in the gastrointestinal tract and readily oxidized to ubiquinone under typical gastric and intestinal conditions. As a result, a substantial portion of ingested ubiquinol may be converted to ubiquinone before absorption even begins. Together, these findings support the concept that the form of CoQ10 consumed does not necessarily determine the form ultimately circulating in the bloodstream or participating in cellular metabolism.

Why Delivery and Formulation Matter

Increasingly, research suggests that formulation characteristics may strongly influence CoQ10 bioavailability, potentially more so than whether the compound is delivered as ubiquinone or ubiquinol. CoQ10 is a highly hydrophobic, lipid‑soluble molecule with a relatively large molecular weight and crystalline structure, which can limit its dissolution and absorption in the gastrointestinal tract. As a result, the dispersion and solubilization of CoQ10 during digestion represent important determinants of absorption.

Because CoQ10 is naturally crystalline and highly lipophilic, it may exist as crystalline aggregates in many conventional supplement formulations, which must first disperse into individual molecules before intestinal absorption can occur, and incomplete dissolution may limit bioavailability. Formulation strategies designed to improve dispersion, such as optimized crystal processing, lipid carriers, emulsified preparations, and self-emulsifying delivery systems, may improve absorption efficiency. 

Several investigations have demonstrated that formulation design can significantly influence CoQ10 absorption. A randomized crossover human bioavailability study (n = 21) found that a solubilized, crystal‑modified ubiquinone formulation achieved plasma CoQ10 levels higher than those produced by a standard oil-based ubiquinol softgel. Another randomized double‑blind crossover trial (n = 14) found that bioavailability differed markedly across seven formulations, with the solubilized ubiquinone softgel showing the highest absorption, surpassing the oil-based ubiquinol softgel, demonstrating that carrier lipids, solubilization efficiency, and certain excipients may significantly impact uptake. Finally, a review study concluded that ubiquinol’s inherent instability and the dominance of formulation factors may undermine claims of its superiority, with several optimized ubiquinone preparations performing as well as or even better than typical ubiquinol products. The carrier matrix used in a supplement, including the type of lipid and emulsification system, may therefore play an important role in determining how effectively CoQ10 is absorbed.

Additionally, CoQ10 absorption can vary considerably between individuals depending on factors such as digestive function, dietary fat intake, age, and overall metabolic health. These variables further highlight the importance of selecting formulations designed to support efficient uptake.

In conclusion, current evidence suggests that both ubiquinone and ubiquinol supplementation may support CoQ10 status, as the body efficiently converts between these two forms. Rather than focusing solely on the redox form, it may be important to also consider formulation characteristics and delivery technologies, as these factors can substantially influence CoQ10 absorption and bioavailability. 

Learn more about CoQ10: 

Your CoQ10 Supplements May be Missing a Key Ingredient: Geranylgeraniol (GG)

The Potential Role of CoQ10 in the Management of Chronic Fatigue Syndrome

CoQ10 Helps Promote Mitochondrial Function

CoQ10 and its Support of Healthy Aging

Gum Health: The Potential Role of CoQ10

By Antonia Toupet, PhD